Trials / Completed

CompletedNCT01596088

A Phase I/II Study of KDX-0811(Dexrazoxane) in the Treatment of Accidental Extravasation of Anthracycline Anti-cancer Agents

A Multicenter, Open Label, Single-arm Study of KDX-0811(Dexrazoxane) in the Treatment of Accidental Extravasation of Anthracycline Anti-cancer Agents

Status: Completed
Phase: Phase 1 / Phase 2
Study type: Interventional
Enrollment: 2 (actual)

Sponsor: Kissei Pharmaceutical Co., Ltd. · Industry
Sex: All
Age: 20 Years
Healthy volunteers: —

Summary

The purpose of this study is to evaluate the efficacy and safety of KDX-0811(Dexrazoxane) in the treatment of accidental extravasation of anthracycline anti-cancer agents.

Conditions

Extravasations of Anthracycline Anti-cancer Agents

Interventions

Type	Name	Description
DRUG	Dexrazoxane

Timeline

Primary completion: 2014-01-01
First posted: 2012-05-10
Last updated: 2015-04-07
Results posted: 2015-03-13

Locations

1 site across 1 country: Japan

Source: ClinicalTrials.gov record NCT01596088. Inclusion in this directory is not an endorsement.